Search
for
Did you mean mTOR inhibitors?
Sort by
Research 30 of 1000+
- 976 Knockout of mTOR/Akt inhibitor REDD1 results in hair cycle-independent dermal adipose expansion by promoting adipocyte differentiation
- ATP-competitive mTOR kinase inhibitors delay plant growth by triggering early differentiation of meristematic cells but no developmental patterning change
- Stimulation by exosomes from hypoxia-preconditioned hair follicle mesenchymal stem cells facilitates mitophagy by inhibiting the PI3K/AKT/mTOR signaling pathway to alleviate ulcerative colitis
- Molecular Genetics of the PI3K-AKT-mTOR Pathway in Genodermatoses: Diagnostic Implications and Treatment Opportunities
- mTOR signaling in hair follicle and hair diseases: recent progress
- 896 Androgens activate lipogenesis through an AKT-independent mTOR pathway stimulation and a limitation of autophagy in an androgen-sensitive sebocyte cell line
- Valproic acid boosts hair follicle stem cell resilience to oxygen-glucose deprivation through autophagy induction and AKT/mTOR suppression
- High doses of cobalt inhibited hair follicle development in Rex Rabbits
- 686 Topical melatonin unfolds differential anti-aging effects in human skin by inhibiting mTORC1 activity via TSC2 stimulation
- Functionally enhanced placenta-derived mesenchymal stem cells inhibit adipogenesis in orbital fibroblasts with Graves’ ophthalmopathy
- Functionally enhanced placenta-derived mesenchymal stem cells inhibit adipogenesis in orbital fibroblasts with Graves’ ophthalmopathy
- Functionally enhanced placenta-derived mesenchymal stem cells inhibit adipogenesis in orbital fibroblasts with Graves’ ophthalmopathy
- Functionally enhanced placenta-derived mesenchymal stem cells inhibit adipogenesis in orbital fibroblasts with Graves’ ophthalmopathy
- Low-Molecular-Weight Fish Collagen Peptide Enhances Hair Regrowth via Activation of Proliferative Signaling and Suppression of Inhibitory Pathways
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- Birt–Hogg–Dubé syndrome: from gene discovery to molecularly targeted therapies
- Disruption of tubular Flcn expression as a mouse model for renal tumor induction
- Premature aging syndromes: From patients to mechanism
- PKC downregulation upon rapamycin treatment attenuates mitochondrial disease
- Patients with bullous skin disease in a high‐epidemic COVID‐19 area, Bergamo, Italy
- Cutaneous Toxicities From Transplantation-Related Medications
- Fibrous Papule of the Face, Similar to Tuberous Sclerosis Complex-Associated Angiofibroma, Shows Activation of the Mammalian Target of Rapamycin Pathway: Evidence for a Novel Therapeutic Strategy?
- Pathological Mechanisms Involved in Epidermolysis Bullosa Simplex: Current Knowledge and Therapeutic Perspectives
- Birt–Hogg–Dubé syndrome
- Protein kinase C is a key target for attenuation of Leigh syndrome by rapamycin
- Dermatologic Care of the Transplant Patient
- Editors' Picks
- Pathogenesis and management of TRPV3-related Olmsted syndrome
- CAQ Corner: Basic concepts of transplant immunology